Strive funds are available through online brokerages firms.
STXI
Strive International Developed Markets ETF
Fund Objective
STXI seeks to track the total return performance, before fees and expenses, of an index composed of developed markets, ex-US securities.
Fund Description
STXI is a passively managed exchange-traded fund (ETF) that seeks to provide diversified exposure to international large- and mid-cap developed markets, excluding US securities. Through Corporate Governance practices, including voting proxy shares and proactively engaging with management teams and boards, Strive aims to unlock value across all corporations in STXI’s portfolio by mandating companies to focus on excellence.
| Fund Data & Pricing | |
|---|---|
| Net Assets as of 09/05/2024 | $10.33m |
| NAV | $25.84 |
| Shares Outstanding | 400,000 |
| Premium/discount Percentage | 0.63% |
| Closing Price | $26.00 |
| Median 30 Day Spread | 0.16% |
Data as of 09/05/2024
IOPV, or Indicative Optimized Portfolio Value, is a calculation disseminated by the stock exchange that approximates the Fund's NAV every fifteen seconds throughout the trading day.
Median 30 Day Spread is a calculation of Fund's median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund's national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.
The Fund expects to declare and to distribute its net investment income, if any, to shareholders as dividends on a monthly basis. The amount of any distribution will vary, and there is no guarantee a Fund will pay either an income dividend or a capital gains distribution.
| Fund Information | |
|---|---|
| Inception Date | 06/26/2024 |
| Primary Exchange | NYSE |
| Ticker | STXI |
| CUSIP | 02072L524 |
| NAV Symbol | STXI.NV |
| Expense Ratio | 0.29% |
| SEC 30-Day Yield | 2.5% |
* As of 07/31/2024
30 Day SEC Yield The yield is calculated with a standardized formula and represents net investment income earned by a fund over a 30-day period, expressed as an annual percentage rate based on the fund's share price. The yield includes the effect of any fee waivers and/or reimbursements. Without waivers, yields would be reduced. This is also referred to as the "standardized yield", “30-Day Yield” and “Current Yield”.
| Performance | Quarter end returns as of 06/30/2024 | |||
|---|---|---|---|---|
| AVG. Annualized | ||||
| Quarter | 1 Year | 3 Year | Since Inception | |
| Fund NAV | - | - | - | -0.68% |
| Market Price | - | - | - | -0.04% |
| Benchmark Index* | - | - | - | -0.56% |
Expense ratio: 0.29%
Inception Date: 06/26/2024
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 855-427-7360. Short term performance, in particular, is not a good indication of the fund's future performance, and an investment should not be made based solely on returns.
Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.
NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.
| Distribution Detail | |||
|---|---|---|---|
| EX- Date | Record Date | Income | Payable Date |
| XXXX | XXXX | XXXX | XXXX |
| TOP 10 HOLDINGS | |||||
|---|---|---|---|---|---|
| % Of Net Assets | Name | Ticker | CUSIP | Shares Held | Market Value |
| 3.04% | Novo Nordisk A/S | NOVOB DC | BP6KMJ1 | 3,278 | 431,782.39 |
| 2.13% | ASML Holding NV | ASML NA | B929F46 | 379 | 302,991.27 |
| 1.85% | Nestle SA | NESN SW | 7123870 | 2,508 | 262,690.55 |
| 1.70% | Novartis AG | NOVN SW | 7103065 | 2,068 | 242,137.77 |
| 1.69% | AstraZeneca PLC | AZN LN | 0989529 | 1,452 | 239,800.87 |
| 1.57% | Roche Holding AG | ROG SW | 7110388 | 682 | 222,987.16 |
| 1.50% | SAP SE | SAP GR | 4846288 | 1,001 | 212,777.24 |
| 1.48% | Shell PLC | SHEL LN | BP6MXD8 | 6,193 | 209,981.28 |
| 1.34% | Toyota Motor Corp | 7203 JP | 6900643 | 10,439 | 190,349.03 |
| 1.17% | LVMH Moet Hennessy Louis Vuitton SE | MC FP | 4061412 | 242 | 166,381.38 |
Data as of 09/06/2024. Holdings are subject to change.
